Centurion Minerals Ltd. (TSXV:CTN) (“Centurion”, or the “Company”) reports that over the last several quarters, management has undertaken a substantive review and evaluation of legal cannabis cultivation, extraction and distribution opportunities in South America, specifically focused on low-cost, stable jurisdictions including Uruguay, Argentina, Paraguay and Peru. A significant portion of this time has been spent assessing consumer preferences and local sensitivities toward cannabis in an effort to develop a sales-focused and consumer-curated cannabis production strategy.

SOUTH AMERICA


Having a larger population than North America, South American countries are moving quickly with varied cannabis legalization presently rolling-out on a country-by-country basis. Brazil alone has a population exceeding 200 million and Centurion envisions a significant business opportunity there following recent cannabis legalization that prohibits any domestic production but allows importation of certain cannabis products.

David Tafel, Centurion’s President & CEO, comments: “We strongly believe there is a near-term opportunity in South America for the Company and investors due to:

  1. A massive population exceeding more than 400 million people;
  2. Broad-based consumer acceptance of cannabis and cannabis derivative products;
  3. Per capita annual spending on cannabis exceeding US$200 in mature markets (Source: Grizzle.com, January 2019);
  4. Limited domestic supply; and
  5. An almost complete lack of capital-markets focus on this region.

2019 IN REVIEW

Centurion management has carefully observed the maturing of the Canadian and American cannabis space over the past 12 months, which includes excess inventory that was inadequately curated for consumer demand as well as cost structures that were misaligned with operational consumer products companies. Both issues have been pervasive across the sector and have been focal points for investor portfolio adjustment.

The Company’s objectives are to develop a sales-oriented, South American focused company that can: (a) produce derivative cannabis products as inputs for consumer products companies; and (b) produce an API isolate for the pharmaceutical industry. On this last point, the Company has ongoing detailed discussions directly and indirectly with multiple South American pharmaceutical companies to quantify potential national and international markets as well as determine potential feasible products and distribution networks.

PATH FORWARD

The Company has narrowed its strategic focus to target Uruguayan CBD distillate and isolate extraction, produced by experienced high-quality technical teams with access to low-cost, high-grade CBD biomass. Subject to implementation of processing activities in Uruguay, the Company intends to incorporate a multi-country business plan approach that involves cultivation and processing operations in Argentina, Paraguay and Peru. Product sales and distribution would target the majority of South America as well as the EU.

centurion table

Management believes one or more transactions with these attributes have the potential to deliver near term/high margin cash flows. Subject to completion of successful negotiations, the Company’s immediate objective is to execute one or more agreements within the first quarter of 2020.

The Company wishes to advise the investing community, that there is no guarantee of success on consummating any new strategic transaction.

PRIVATE PLACEMENT

Further to the Company’s November 1, 2019 news release announcing a first tranche private placement financing, the Company will not proceed with additional tranches to this financing.

ABOUT CENTURION

Centurion Minerals Ltd. is a Canadian-based company with a focus on South American asset development. The Company’s lead investment is its interest in the Ana Sofia Agri-Gypsum Fertilizer Project. In addition, the Company is actively pursuing business opportunities in the South American cannabis and related products industry.

“David G. Tafel”
President and CEO

For Further Information Contact:
David Tafel
604-484-2161

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward looking statements concerning future operations of Centurion Minerals Ltd. (the “Company”). All forward-looking statements concerning the Company’s future plans and operations, including management’s assessment of the Company’s project expectations or beliefs may be subject to certain assumptions, risks and uncertainties beyond the Company’s control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and exploration and financial results may differ materially from any estimates or projections. Such statements include, among others: possible variations in mineralization, grade or recovery rates; actual results of current exploration activities; actual results of reclamation activities; conclusions of future economic evaluations; changes in project parameters as plans continue to be refined; failure of equipment or processes to operate as anticipated; accidents and other risks of the mining industry; delays and other risks related to construction activities and operations; timing and receipt of regulatory approvals of operations; the ability of the Company and other relevant parties to satisfy regulatory requirements; the availability of financing for proposed transactions, programs and working capital requirements on reasonable terms; the ability of third-party service providers to deliver services on reasonable terms and in a timely manner; market conditions and general business, economic, competitive, political and social conditions.

Source

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less